Keywords: b-ms/merck, co, pargluva, sees, strong, ph, iii/ii

B-MS/Merck & Co's Pargluva sees strong Ph III/II data

Article | 11 July 2005

Print This

Bristol-Myers Squibb and fellow US drugmaker Merck & Co have released strong results from a Phase III active-controlled study and a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in